Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Cardiovascular Diseases

arginyl-glycyl-aspartic acid has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, JM; Case, AJ; Jayaseharan, J; Kottke-Marchant, K; Lestini, BJ; Marchant, RE; Richter, NJ; Sagnella, SM; Shive, MS; Xu, Z1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Cardiovascular Diseases

ArticleYear
Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery.
    Journal of controlled release : official journal of the Controlled Release Society, 2002, Jan-17, Volume: 78, Issue:1-3

    Topics: Animals; Cardiovascular Diseases; Dextrans; Drug Delivery Systems; Female; Liposomes; Mice; Mice, Inbred BALB C; Oligopeptides; Oligosaccharides; Platelet Glycoprotein GPIIb-IIIa Complex

2002